Twelve-Week MiDAS I Clinical Study Data Confirm Safety, Efficacy of Vertos … Earthtimes Vertos Medical was founded to advance the treatment of patients suffering with lumbar spinal stenosis (LSS), a degenerative, age-related narrowing of the …

View post:
Twelve-Week MiDAS I Clinical Study Data Confirm Safety, Efficacy of Vertos … – Earthtimes

Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild for the treatment of lumbar spinal stenosis (LSS)

Here is the original post:
Vertos Medical announces positive results from IRB I Patient Outcomes Trial of ‘mild’ for LSS (News-Medical-Net)

ALISO VIEJO, Calif.—-Medical device company Vertos Medical Inc. has announced the release of positive results from its U.S. IRB I Patient Outcomes Trial, a prospective, investigational review board-approved, 75-patient study of mild* for the treatment of lumbar spinal stenosis .

Link:
Vertos Medical’s Prospective Outcomes Study Demonstrates Efficacy, Validates Safety Profile of mild® (Business Wire via Yahoo! Finance)

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

The rest is here:
Observational study on mild demonstrates acute safety of procedure in treatment of LSS (News-Medical-Net)

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

Excerpt from:
Observational study on mild demonstrates acute safety of procedure in treatment of LSS (News-Medical-Net)

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

Visit link:
Observational study on mild demonstrates acute safety of procedure in treatment of LSS

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

Continue reading here:
Observational study on mild demonstrates acute safety of procedure in treatment of LSS

ALISO VIEJO, Calif.—-Medical device company Vertos Medical Inc.

Go here to see the original:
Acute Study Demonstrates Safety of Vertos Medical’s mild® Procedure; Findings Appear in Pain Physician Journal (Business Wire via Yahoo! Finance)

Medical device company Vertos Medical, Inc., developer of the mild® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing.

Read this article:
Vertos Medical raises $15.5 million for U.S. commercialization of the company’s "mild" technology